Argan Inc SEC Filings

Argan, Inc. announced that subsidiary Gemma Power Systems received full notice to proceed on an EPC contract for CPV’s Basin Ranch Energy Center in Ward County, Texas. The project is a 1,350 MW 2–1×1 combined-cycle power plant using GE 7HA.03 turbines, designed with an option to add carbon capture capability.

Construction is expected to begin this fall, with a scheduled completion in 2028. Argan stated that the full amount of the contract value will be included in its consolidated project backlog for the period ending October 31, 2025. This adds a sizable long-duration power project to Gemma’s pipeline, aligning with utility-scale gas generation and optional decarbonization features.

Argan Inc. (AGX) director Peter W. Getsinger reported open‑market sales of the company’s common stock. He sold 2,000 shares at $292 on October 17, 2025 and 6,493 shares at $294.39 on October 20, 2025.

Following these transactions, he directly holds 9,897 shares of Argan common stock. The filing identifies him as a Director and lists the transactions as open‑market sales reported on a Form 4.

Argan, Inc. (AGX) director Peter W. Getsinger reported insider transactions on Form 4. On October 15, 2025, he exercised an option to purchase 10,000 shares at $46.35 per share using a net settle method, resulting in 8,493 shares acquired. That same day, he gifted 333 shares to each of his three children, totaling 999 shares. On October 16, 2025, he transferred 1,000 shares to a donor advised fund managed by Martha's Vineyard Investment Advisors.

Following these transactions, his directly held position was 18,390 shares. The option was originally awarded on January 11, 2018, became exercisable on January 11, 2019, and has an expiration date of January 11, 2028.

Argan, Inc. (AGX) reported insider activity by an officer on 10/15/2025. The reporting person exercised stock options to acquire 5,235 shares at $42.31 and 4,765 shares at $33.81, then conducted an open‑market sale of 10,000 shares at an average price of $309.37.

Following these transactions, the filer reported 21,006 shares of common stock held directly. The reporting person is identified as Chief Executive Officer, Gemma.

AGX: A shareholder filed a Form 144 notice to sell 2,000 common shares, reflecting an aggregate market value of $584,000. The filing lists an approximate sale date of 10/17/2025 on the NYSE, with Morgan Stanley Smith Barney LLC as broker. Shares outstanding were 13,811,575.

The seller acquired 2,000 shares on 10/17/2025 via an option exercise under a registered plan paid in cash. Recent activity disclosed includes prior sales over the last three months: 1,000 shares on 09/19/2025 for $264,535.10 and 2,609 shares on 09/17/2025 for $625,325.12.

Argan, Inc. (AGX) insider activity: On October 13, 2025, a company officer exercised stock options and sold shares. The officer exercised 5,235 options at $43.10 and 4,765 options at $42.31, then sold 10,000 shares on the open market at an average price of $292.09. Following these transactions, the officer directly owned 21,006 common shares.

The reporting person is identified as an Officer (Chief Executive Officer, Gemma). The filing notes the transactions and resulting holdings, providing transparency into recent insider equity movements.

Argan Inc. (AGX): Director ownership change

Director James W. Quinn reported an internal transfer of 5,578 shares of Argan common stock on 10/10/2025, coded J, at a price of $0. The shares moved from the James W. Quinn 2025 GRAT No. 1 (indirect) to his direct ownership, which the report explains is a change in the form of beneficial ownership and not a sale.

Following the transactions, the filing shows 43,992 shares held indirectly via the GRAT and 5,578 shares held directly.

Director and CEO David H. Watson reported multiple stock transactions on 10/09/2025. He sold 4,441 shares on the open market at an average price of $277.01 per share and gifted 559 shares to the David and Laura Watson Foundation (a donor-advised fund). The Foundation then sold the 559 shares at $272.27 per share. After these reported transactions the filing shows the Reporting Person beneficially owned 47,132 shares directly.

Argan, Inc. (AGX) filed a Form 144 notice indicating a proposed sale of 4,441 shares of common stock through Raymond James & Associates on 10/09/2025. The filing lists an aggregate market value of $1,245,656.09 and shows 13,811,575 shares outstanding, implying the sale represents a very small fraction of the company.

The shares were acquired on 09/10/2024 as an equity grant and paid via option exercise on the same date. No other sales in the prior three months were reported. The filing includes the standard Rule 144 representation that the seller is not aware of undisclosed material adverse information.